Patients' and clinicians' preferences in adjuvant treatment for high-risk endometrial cancer: implications for shared decision making.

Author(s):: Post, C.C.B. (0000-0003-2534-6887); Mens, J.W.M.; Haverkort, M.A.D.; Koppe, F.; Jurgenliemk-Schulz, I.M.; Snyers, A.; Roeloffzen, E.M.A.; Schaake, E.E.; Slot, A.; Stam, T.C.; Beukema, J.C.; Berg, H.A. van den; Lutgens, L.C.H.W.; Nijman, H.W.; Kroon, C.D. de; Kroep, J.R. (0000-0003-2671-1903); Stiggelbout, A.M. (0000-0002-6293-4509); Creutzberg, C.L. (0000-0002-7008-4321)

Published: 2021
Publication type: Article / Letter to editor

Date issued: 2021-06-01
Language: English
Is part of: Gynecologic Oncology (2021), Vol. 161, no. 3, p. 727-733
hdl: 1887/3276102
doi: 10.1016/j.ygyno.2021.03.004
URL: http://www.gynecologiconcology-online.net/article/S0090825821001980/pdf